170 related articles for article (PubMed ID: 32000891)
1. Quantitation of calreticulin exposure associated with immunogenic cell death.
Liu P; Zhao L; Kepp O; Kroemer G
Methods Enzymol; 2020; 632():1-13. PubMed ID: 32000891
[TBL] [Abstract][Full Text] [Related]
2. Side-by-side comparison of flow cytometry and immunohistochemistry for detection of calreticulin exposure in the course of immunogenic cell death.
Kasikova L; Truxova I; Cremer I; Sautes-Fridman C; Kepp O; Kroemer G; Spisek R; Fucikova J
Methods Enzymol; 2020; 632():15-25. PubMed ID: 32000894
[TBL] [Abstract][Full Text] [Related]
3. Quantitative determination of phagocytosis by bone marrow-derived dendritic cells via imaging flow cytometry.
Cerrato G; Liu P; Martins I; Kepp O; Kroemer G
Methods Enzymol; 2020; 632():27-37. PubMed ID: 32000900
[TBL] [Abstract][Full Text] [Related]
4. Interference of immunogenic chemotherapy by artificially controlled calreticulin secretion from tumor cells.
Zhao L; Zhang S; Chen H; Kroemer G; Kepp O; Liu P
Methods Cell Biol; 2022; 172():99-114. PubMed ID: 36064229
[TBL] [Abstract][Full Text] [Related]
5. Quinacrine-mediated detection of intracellular ATP.
Forveille S; Humeau J; Sauvat A; Bezu L; Kroemer G; Kepp O
Methods Enzymol; 2019; 629():103-113. PubMed ID: 31727236
[TBL] [Abstract][Full Text] [Related]
6. Calreticulin Exposure in Mitotic Catastrophe.
Bezu L; Kepp O; Kroemer G
Methods Mol Biol; 2021; 2267():207-215. PubMed ID: 33786794
[TBL] [Abstract][Full Text] [Related]
7. Sequential Interferon β-Cisplatin Treatment Enhances the Surface Exposure of Calreticulin in Cancer Cells via an Interferon Regulatory Factor 1-Dependent Manner.
Yang PM; Hsieh YY; Du JL; Yen SC; Hung CF
Biomolecules; 2020 Apr; 10(4):. PubMed ID: 32326356
[TBL] [Abstract][Full Text] [Related]
8. Quantification of eIF2alpha phosphorylation during immunogenic cell death.
Bezu L; Wu Chuang A; Humeau J; Kroemer G; Kepp O
Methods Enzymol; 2019; 629():53-69. PubMed ID: 31727256
[TBL] [Abstract][Full Text] [Related]
9. Resistance to anticancer vaccination effect is controlled by a cancer cell-autonomous phenotype that disrupts immunogenic phagocytic removal.
Garg AD; Elsen S; Krysko DV; Vandenabeele P; de Witte P; Agostinis P
Oncotarget; 2015 Sep; 6(29):26841-60. PubMed ID: 26314964
[TBL] [Abstract][Full Text] [Related]
10. Immunogenic cell death in cancer therapy: Present and emerging inducers.
Zhou J; Wang G; Chen Y; Wang H; Hua Y; Cai Z
J Cell Mol Med; 2019 Aug; 23(8):4854-4865. PubMed ID: 31210425
[TBL] [Abstract][Full Text] [Related]
11. eIF2α phosphorylation is pathognomonic for immunogenic cell death.
Bezu L; Sauvat A; Humeau J; Gomes-da-Silva LC; Iribarren K; Forveille S; Garcia P; Zhao L; Liu P; Zitvogel L; Senovilla L; Kepp O; Kroemer G
Cell Death Differ; 2018 Aug; 25(8):1375-1393. PubMed ID: 29358668
[TBL] [Abstract][Full Text] [Related]
12. Immunosuppression by Mutated Calreticulin Released from Malignant Cells.
Liu P; Zhao L; Loos F; Marty C; Xie W; Martins I; Lachkar S; Qu B; Waeckel-Énée E; Plo I; Vainchenker W; Perez F; Rodriguez D; López-Otin C; van Endert P; Zitvogel L; Kepp O; Kroemer G
Mol Cell; 2020 Feb; 77(4):748-760.e9. PubMed ID: 31785928
[TBL] [Abstract][Full Text] [Related]
13. Molecular determinants of immunogenic cell death: surface exposure of calreticulin makes the difference.
Chaput N; De Botton S; Obeid M; Apetoh L; Ghiringhelli F; Panaretakis T; Flament C; Zitvogel L; Kroemer G
J Mol Med (Berl); 2007 Oct; 85(10):1069-76. PubMed ID: 17891368
[TBL] [Abstract][Full Text] [Related]
14. Process of immunogenic cell death caused by disulfiram as the anti-colorectal cancer candidate.
You SY; Rui W; Chen ST; Chen HC; Liu XW; Huang J; Chen HY
Biochem Biophys Res Commun; 2019 Jun; 513(4):891-897. PubMed ID: 31003768
[TBL] [Abstract][Full Text] [Related]
15. Immune Monitoring of Cancer Patients by Multi-color Flow Cytometry.
Neo SY; O'Reilly A; Pico de Coaña Y
Methods Mol Biol; 2019; 1913():49-65. PubMed ID: 30666598
[TBL] [Abstract][Full Text] [Related]
16. Human tumor cells killed by anthracyclines induce a tumor-specific immune response.
Fucikova J; Kralikova P; Fialova A; Brtnicky T; Rob L; Bartunkova J; Spísek R
Cancer Res; 2011 Jul; 71(14):4821-33. PubMed ID: 21602432
[TBL] [Abstract][Full Text] [Related]
17. Silver nanoparticles induce a non-immunogenic tumor cell death.
Garcia Garcia MR; Casares N; Martinez Perez LA; Juarez Curiel E; de Jesus Hernandez AA; Bogdanchikova N; Garibo D; Rodriguez-Hernandez AG; Pestryakov A; Castro Gamboa S; Arias Ruiz LF; Torres Bugarin O; Berraondo P
J Immunotoxicol; 2023 Dec; 20(1):2175078. PubMed ID: 36773297
[TBL] [Abstract][Full Text] [Related]
18. Natural modulators of the hallmarks of immunogenic cell death.
Radogna F; Dicato M; Diederich M
Biochem Pharmacol; 2019 Apr; 162():55-70. PubMed ID: 30615863
[TBL] [Abstract][Full Text] [Related]
19. Clinically relevant GABARAP deficiency abrogates bortezomib-induced immunogenic cell death in multiple myeloma.
Zhao L; Shen Z; Kroemer G; Kepp O
Oncoimmunology; 2024; 13(1):2360275. PubMed ID: 38812570
[TBL] [Abstract][Full Text] [Related]
20. Immunogenic cell death inducer peptides: A new approach for cancer therapy, current status and future perspectives.
Aria H; Rezaei M
Biomed Pharmacother; 2023 May; 161():114503. PubMed ID: 36921539
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
